Hikma Pharmaceuticals PLC
HKMPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,338,558 | $5,094,235 | $4,221,756 | $6,615,840 |
| - Cash | $188,000 | $205,000 | $270,000 | $426,000 |
| + Debt | $1,306,000 | $1,191,000 | $1,283,000 | $846,000 |
| Enterprise Value | $6,456,558 | $6,080,235 | $5,234,756 | $7,035,840 |
| Revenue | $3,127,000 | $2,875,000 | $2,517,000 | $2,553,000 |
| % Growth | 8.8% | 14.2% | -1.4% | – |
| Gross Profit | $1,415,000 | $1,407,000 | $1,265,000 | $1,301,000 |
| % Margin | 45.3% | 48.9% | 50.3% | 51% |
| EBITDA | $787,000 | $791,000 | $691,000 | $705,000 |
| % Margin | 25.2% | 27.5% | 27.5% | 27.6% |
| Net Income | $359,000 | $190,000 | $188,000 | $421,000 |
| % Margin | 11.5% | 6.6% | 7.5% | 16.5% |
| EPS Diluted | 1.61 | 0.85 | 0.84 | 1.81 |
| % Growth | 89.4% | 1.2% | -53.6% | – |
| Operating Cash Flow | $564,000 | $608,000 | $530,000 | $638,000 |
| Capital Expenditures | -$165,000 | -$169,000 | -$138,000 | -$145,000 |
| Free Cash Flow | $399,000 | $439,000 | $392,000 | $493,000 |